Literature DB >> 680948

Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole.

D E Griswold, D T Walz.   

Abstract

The effect of levamisole upon cell-mediated immunity was investigated using the oxazolone-induced contact sensitivity response in immunosuppressed and nonimmunosuppressed C57Bl male mice. Mice were sensitized to oxazolone on day 0, and where appropriate, methotrexate (1 mg/kg, p.o.) was administered on days 1 and 2. On day 3, levamisole (5--50 mg/kg, p.o., base) was administered. One hour later, the animals were challenged with oxazolone on the left hindpaw. Twenty-four hours after challenge, the resulting edema was read plethysmographically. Levamisole, in the absence of immunosuppression, had no significant effect upon the oxazolone response whereas, in the face of immunosuppression, restoration of oxazolone responsiveness was observed. These results were suggested to be due to (1) the ability of levamisole to stimulate opposing suppressor and effector components of the oxazolone response coupled with (2) an apparent alteration of suppressor influence by methotrexate allowing levamisole to enhance an unencumbered effector cell population.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680948     DOI: 10.1007/BF00917326

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  18 in total

1.  Letter: Levamisole (NSC-177023) in clinical immunotherapy.

Authors:  W K Amery
Journal:  Cancer Treat Rep       Date:  1976-03

2.  The effect of levamisole on cell-mediated immunity and suppressor cell function.

Authors:  D Sampson; A Lui
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

3.  Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole.

Authors:  J Symoens; J Brugmans
Journal:  Br Med J       Date:  1974-12-07

4.  Quantification and pharmacological dissection of oxazolone-induced contact sensitivity in the mouse.

Authors:  D E Griswold; J A DiLorenzo; P Calabresi
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

5.  Adjuvant-induced arthritis in rats. I. Temporal relationship of physiological, biochemical, and hematological parameters.

Authors:  D T Walz; M J DiMartino; J H Kuch; W Zuccarello
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

6.  Letter: Levamisole in rheumatoid arthritis.

Authors:  Y Schuermans
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

7.  Letter: Levamisole in the treatment of cancer.

Authors:  H W Ward
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

8.  In vitro parameters of cell-mediated immune reactions in healthy individuals following immune-stimulation attempts with levamisole.

Authors:  H Thulin; K Thestrup-Pedersen; J Ellegaard
Journal:  Acta Allergol       Date:  1975-04

9.  Condition-dependent immunoregulatory control of contact sensitivity by levamisole.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

10.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  1 in total

1.  Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162): effects on cell-mediated immunity.

Authors:  D T Walz; D E Griswold
Journal:  Inflammation       Date:  1978-06       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.